Committee for Orphan Medicinal Products (COMP): 3-5 November 2026
Date:
03/11/2026 to 05/11/2026
Location:
European Medicines Agency, Amsterdam, the Netherlands
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.